Notable Stock to Watch: Healthcare Trust of America (NYSE:HTA)

Healthcare Trust of America (NYSE:HTA) spotted trading -1.65% off 52-week high price. On the other end, the stock has been noted 25.36% away from the low price over the last 52-weeks. The stock changed 0.40% to recent value of $30.35. The stock transacted 1874822 shares during most recent day however it has an average volume of 1339.08K shares. The company has 205.16M of outstanding shares and 204.04M shares were floated in the market.  

 On Oct. 28, 2019, Healthcare Trust of America (NYSE:HTA) announced results for the three and nine months ended September 30, 2019.

HTA’s Q3 2019 results consist of a net loss attributable to common stockholders of $(0.04) per diluted share, which included a ($0.10) per share charge related to the refinancing of the 2021 and 2022 Senior Notes, Normalized FFO of $0.42 per diluted share, and Same-Property Cash NOI growth of 2.5%.  In the quarter, HTA completed $135.5 million in acquisitions, announced two new developments totaling $90.0 million, and refinanced $900.0 million in debt at 3.05% per annum blended interest rates. As a result of this performance, HTA is adjusting its EPS guidance to account for the debt extinguishment costs, while reiterating its normalized FFO guidance, increasing its midpoint for full year same store growth, and increasing the volume of acquisitions as outlined below.

In the third quarter, HTA demonstrated its ability to drive both internal and external growth while strengthening its fortress balance sheet and positioning itself for the future, stated Chairman, CEO and President Scott D. Peters. Our operating results demonstrate the power of our company.  We have a best-in-class portfolio concentrated in key markets, and an operating platform that can create value for our tenants and shareholders through operations, development, and acquisitions.

 Its earnings per share (EPS) expected to touch remained 194.60% for this year. HTA has a gross margin of 68.70% and an operating margin of 21.90% while its profit margin remained 31.70% for the last 12 months. 

  The price moved ahead of 1.82% from the mean of 20 days, 4.73% from mean of 50 days SMA and performed 7.49% from mean of 200 days price. Company’s performance for the week was -0.69%, 2.64% for month and YTD performance remained 19.91%.

Leave a Reply

Your email address will not be published. Required fields are marked *